Stock Ticker

  • Loading stock data...

TrovaGene Inc (NASDAQ:TROV) Expands Clinical Trial to Include Precision Cancer Monitoring Platform In Lung Cancer

Boston, MA 09/30/2014 (wallstreetpr) – Development-stage molecular diagnostic company, TrovaGene Inc (NASDAQ:TROV) disclosed that it has expanded its clinical trial program to include precision cancer monitoring platform in lung cancer patients management. Expands Program According to TrovaGene Inc (NASDAQ:TROV)’s statement, the principal aim of the trial expansion was to identify and monitor EGFR alterations in […]

Sign Up To Get Our Latest Stocks Alerts